New Covid-19 variant Nimbus raises concerns, but South Africa remains case-free
The National Institute for Communicable Diseases (NICD) says it's closely monitoring the emergence of a new Covid-19 variant, identified in several Asian countries.
"The latest variant, Nimbus or NB.1.8.1, has been designated a SARS-CoV-2 variant under monitoring.
"In South Africa, we have also not detected this lineage yet, and using our sentinel syndromic surveillance system, there are very few outpatient or inpatient respiratory illnesses caused by SARS-COV-2," the NICD said.
According to the National Department of Health, the new variant is a descendant of the Omicron lineage.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TimesLIVE
2 days ago
- TimesLIVE
Top 5 things to know as chikungunya spreads to holiday hotspots
The National Institute for Communicable Diseases (NICD) has urged South Africans, especially travellers, to be alert to the risks of chikungunya fever as outbreaks continue in several popular holiday destinations. Chikungunya is a category 3 notifiable medical condition in South Africa and is caused by the mosquito-borne chikungunya virus transmitted mainly by the Aedes aegypti and Aedes albopictus mosquitoes. While the disease is endemic in parts of Africa, Asia, the Americas and the Pacific, sporadic cases in South Africa are mostly linked to travellers returning from outbreak areas. 1. Imported cases in 2025 Between December 2024 and July 28, South Africa recorded 10 laboratory-confirmed cases of chikungunya, all in returning travellers. Travel histories showed: four cases from Mauritius; one from Kenya; one from India and the Himalayas; one from La Réunion; one from Seychelles; and two cases from Madagascar. 2. Global outbreak hotspots 'By May 2025, the Americas reported the highest number of chikungunya cases globally — 135,654, including 54,377 confirmed infections,' said the NICD. Outbreaks have been reported in La Réunion, Mayotte, Mauritius, Madagascar, Kenya, Somalia and Sri Lanka. La Réunion has seen more than 47,500 cases and 12 deaths this year. 3. How the virus spreads Chikungunya is not spread person-to-person. Local outbreaks can occur when a viremic traveller is bitten by an Aedes mosquito which then transmits the virus to other residents. 'The presence of Aedes aegypti in urban areas means the risk of potential local outbreaks should be considered, especially along the east coast, in KwaZulu-Natal and the Eastern Cape, and in Gauteng,' the NICD warned. 4. Symptoms and diagnosis Common symptoms include fever, muscle aches, rash, joint pain (arthralgia) and arthritis. Though usually self-limiting, the illness can be severe and occasionally lead to chronic arthritis. Diagnosis is based on symptoms, travel history and confirmed through RT-PCR or serology testing available at the NICD/NHLS and private labs. 5. Prevention and travel advice The NICD advised people to 'prevent mosquito bites, especially during the day and late afternoon.' Recommended measures include: using insect repellent on exposed skin; wearing long-sleeved clothing and trousers; and staying in air-conditioned or screened environments. Pregnant women are advised to reconsider travel to outbreak areas due to possible health risks. There is no widely available vaccine for chikungunya and none is available in South Africa. The NICD said travellers should seek medical care if they experience fever, joint pain, headache, muscle aches, swelling or rash within 14 days of returning from an affected region.
IOL News
4 days ago
- IOL News
Glenmore's R2bn claims against health service providers dismissed by Competition Tribunal
The decision comes after the Tribunal upheld exceptions filed by both the National Health Laboratory Service (NHLS) and AfroCentric Health, citing multiple deficiencies in Glenmore's case. Image: Supplied The Competition Tribunal has ruled against Glenmore Capital, dismissing its complaint regarding the alleged exclusion of its COVID-19 rapid antigen test kits from the South African public and private sectors. The decision comes after the Tribunal upheld exceptions filed by both the National Health Laboratory Service (NHLS) and AfroCentric Health, citing multiple deficiencies in Glenmore's case. Glenmore's complaint, originally lodged with the Competition Commission in August 2022, sought damages nearing R2 billion, claiming that NHLS and AfroCentric engaged in exclusionary practices that barred it from entering the market for COVID-19 test kits. The Commission, however, chose not to pursue the case, citing Glenmore's struggle to achieve market acceptance as a result of commercial factors, including delays in regulatory approval and a decrease in demand as the COVID-19 pandemic waned. Frustrated with the Commission's decision, Glenmore escalated the matter to the Tribunal. At a pre-hearing in December 2024, Glenmore was afforded an opportunity to amend its founding affidavit to address the concerns raised by NHLS and AfroCentric. Despite making amendments, both defendants argued that Glenmore's case remained fundamentally flawed. Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Advertisement Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Next Stay Close ✕ In its defence, NHLS and AfroCentric articulated four primary exceptions, asserting that Glenmore's complaint lacked a valid cause of action, failed to properly identify the legal entities involved, lacked a clear market definition, and exceeded the Tribunal's jurisdiction due to the nature of the claims made. No valid cause of action: Glenmore's complaint failed to establish a legal basis under the Competition Act, lacking both legal and factual foundation. Glenmore's complaint failed to establish a legal basis under the Competition Act, lacking both legal and factual foundation. Improper citation of entities: Glenmore did not adequately identify which legal entity allegedly contravened the Act, despite having been given several opportunities to rectify this. Lack of proper market definition: The complaint failed to clarify the relevant market, with Glenmore shifting references between disparate health products without defining a cohesive product or geographic market. The complaint failed to clarify the relevant market, with Glenmore shifting references between disparate health products without defining a cohesive product or geographic market. Lack of jurisdiction and procedural issues: The Tribunal highlighted that it cannot award damages unless under consent orders and noted allegations outside the ambit of competition law, such as irregular procurement and insider trading. The Tribunal noted that Glenmore had been granted ample opportunity to clarify and bolster its case but ultimately failed to provide a coherent argument. With the exceptions upheld, Glenmore's complaint referral was dismissed in its entirety. BUSINESS REPORT
Daily Maverick
5 days ago
- Daily Maverick
PinkDrive's innovative campaign aims to screen 12,000 people and educate communities on cancer
In an effort to tackle late-stage cancer detection, a mobile screening drive run by the NGO PinkDrive, mining group Rio Tinto and the Department of Health is bringing key services to underresourced communities across four provinces. A mobile cancer screening drive is bringing much-needed services to underresourced communities in KwaZulu-Natal, the Eastern Cape, the Northern Cape and Mpumalanga. Spearheaded by the health sector NGO PinkDrive, the campaign aims to screen more than 12,000 individuals by the end of August and provide health education to many more. The initiative, supported by mining group Rio Tinto and the National Department of Health, is driven by the need to address late-stage cancer detection. 'There aren't such [screening] services available in many of the areas… and access to where there's services is… just about nonexistent for the communities… That's why [PinkDrive] took the mobile approach some 20 years ago now. Our whole thing is to take the health service to the people who cannot afford it, and make it easily accessible,' explained Noelene Kotschan, CEO and founder of PinkDrive. 'In the communities, these people that we are seeing are the poorest of the poor. They don't have the disposable income to pay for taxis to take them to the hospital for a service… This is all done on the spot.' As part of the campaign, PinkDrive is providing mammograms and pap smears for cervical cancer detection and HPV (Human papillomavirus) screening, as well as check-ups for prostate cancer, skin cancers, high blood pressure and glucose and cholesterol monitoring. There are 18 medical professionals on the mobile screening team, including a gynaecologist, dermatologist and radiologist. 'Because we have highly skilled medical doctors, as well as trained nurses, we are in a position to immediately refer patients to the closest hospital or the clinic where they come from, so that they can access treatment as fast as possible. Our [memorandum of understanding] with the National Department of Health is to do the screening, and then the uptake of the patients for whom we created a pathway to care is the state's responsibility,' said Kotschan. Community health education PinkDrive's outreach efforts extend to providing health education in the communities to which they travel, ensuring individuals are better equipped to monitor their own health. 'According to our licence, we can only do 30 mammograms a day, because we are… fully licensed via the Health Professions Council [of South Africa], so you can imagine the need versus the number that we can do. However, we're very focused on educating as well,' Kotschan told Daily Maverick. While the screening service prioritises mammograms for women over 40 years of age, the team's medical staff also show men and women of all ages how to perform clinical breast examinations on themselves. Kotschan said: 'We've found that stats worldwide are showing breast cancer is no longer an older woman's disease. The younger girls are also [at risk]. Yesterday, we picked up a 20-year-old and a 33-year-old who have definitely got breast cancer… On those women, ultrasounds are done, biopsies are done.' According to Statistics South Africa's report on cancer in South Africa (2008-19), released in 2023, cancer accounted for 9.7% of all deaths reported in the country in 2018, making it the fourth-leading cause of mortality. Working with communities Kotschan said the response to the cancer screening drive in communities had been 'amazing'. 'There's a lot of ground mobilisation that has been done… The districts and clinics where we go, their community health workers, I must commend them. They've done a phenomenal job,' she said. Residents who took part in PinkDrive's screening efforts at Motherwell Clinic in the Eastern Cape said they were thankful for the opportunity to access health checks. Speaking anonymously, one woman said: 'Today, at Motherwell Clinic, they had such great services from the PinkDrive… I had a pap smear, a lung screening, skin cancer screening, and I got the best out of everything. I would have never had the opportunity if the PinkDrive wasn't a part of it.' Mandisa Mabaso, head of government relations at Rio Tinto, said the company's partnership with PinkDrive was part of its broader social impact strategy, 'focused on balancing economic growth with environmental and social responsibility'. 'We understand that sustainable change requires collaboration, and together with experts and local authorities, we can address critical social needs for a healthier future,' Mabaso said. DM
